Javascript must be enabled to continue!
Effect of hypertonic vs isotonic saline solution on responses to sublethal Escherichia coli endotoxemia in horses
View through CrossRef
SUMMARY
Cardiovascular responses to sublethal endotoxin infusion (Escherichia coli, 50 μg/ml in lactated Ringer solution at 100 ml/h until pulmonary arterial pressure increased by 10 mm of Hg) were measured 2 times in 5 standing horses. In a 2-period crossover experimental design, horses were either administered hypertonic (2,400 mosm/kg of body weight, iv) or isotonic (300 mosm/kg, iv) NaCl solution after endotoxin challenges. Each solution was administered at a dose of 5 ml/kg (infusion rate, 80 ml/min). Complete data sets (mean arterial, central venous, and pulmonary arterial pressures, pulmonary arterial blood temperature, cardiac output, total peripheral vascular resistance, heart rate, plasma osmolality, plasma concentration of Na, K, Cl, and total protein, blood lactate concentration, and pcv) were collected at 0 (baseline, before endotoxin infusion), 0.25, 1, 1.5, 2, 2.5, 3, 3.5, 4, and 4.5 hours after initiation of the endotoxin infusion. Blood constituents alone were measured at 0.5 hour and cardiovascular variables alone were evaluated at 0.75 hour. By 0.25 hour, endotoxin infusion was completed, a data set was collected, and saline infusion was initiated. By 0.75 hour, saline solutions had been completely administered.
Mean (± sem) cardiac output decreased (99.76 ± 3.66 to 72.7 ± 2.35 ml/min/kg) and total peripheral resistance (1.0 ± 0.047 to 1.37 ± 0.049 mm of Hg/ml/min/kg) and pulmonary arterial pressure (33.4 ± 0.86 to 58.3 ± 1.18 mm of Hg) increased for both trials by 0.25 hour after initiation of the endotoxin infusion and prior to fluid administration. For the remainder of the protocol, cardiac output was increased and total peripheral resistance was decreased during the hypertonic, compared with the isotonic, saline trial. Cardiac output was decreased and total peripheral resistance was increased during the isotonic saline trial, compared with baseline values. Both trials were associated with increased blood lactate concentration, but lactate values during the isotonic saline trial were greater and remained increased above baseline values for a longer period (4 hours) than during the hypertonic saline trial (2.5 hours). It was concluded for this model of endotoxemia, that iv administered hypertonic saline solution was associated with more-desirable cardiovascular and metabolic responses than was an equal volume of isotonic saline solution.
American Veterinary Medical Association (AVMA)
Title: Effect of hypertonic vs isotonic saline solution on responses to sublethal Escherichia coli endotoxemia in horses
Description:
SUMMARY
Cardiovascular responses to sublethal endotoxin infusion (Escherichia coli, 50 μg/ml in lactated Ringer solution at 100 ml/h until pulmonary arterial pressure increased by 10 mm of Hg) were measured 2 times in 5 standing horses.
In a 2-period crossover experimental design, horses were either administered hypertonic (2,400 mosm/kg of body weight, iv) or isotonic (300 mosm/kg, iv) NaCl solution after endotoxin challenges.
Each solution was administered at a dose of 5 ml/kg (infusion rate, 80 ml/min).
Complete data sets (mean arterial, central venous, and pulmonary arterial pressures, pulmonary arterial blood temperature, cardiac output, total peripheral vascular resistance, heart rate, plasma osmolality, plasma concentration of Na, K, Cl, and total protein, blood lactate concentration, and pcv) were collected at 0 (baseline, before endotoxin infusion), 0.
25, 1, 1.
5, 2, 2.
5, 3, 3.
5, 4, and 4.
5 hours after initiation of the endotoxin infusion.
Blood constituents alone were measured at 0.
5 hour and cardiovascular variables alone were evaluated at 0.
75 hour.
By 0.
25 hour, endotoxin infusion was completed, a data set was collected, and saline infusion was initiated.
By 0.
75 hour, saline solutions had been completely administered.
Mean (± sem) cardiac output decreased (99.
76 ± 3.
66 to 72.
7 ± 2.
35 ml/min/kg) and total peripheral resistance (1.
0 ± 0.
047 to 1.
37 ± 0.
049 mm of Hg/ml/min/kg) and pulmonary arterial pressure (33.
4 ± 0.
86 to 58.
3 ± 1.
18 mm of Hg) increased for both trials by 0.
25 hour after initiation of the endotoxin infusion and prior to fluid administration.
For the remainder of the protocol, cardiac output was increased and total peripheral resistance was decreased during the hypertonic, compared with the isotonic, saline trial.
Cardiac output was decreased and total peripheral resistance was increased during the isotonic saline trial, compared with baseline values.
Both trials were associated with increased blood lactate concentration, but lactate values during the isotonic saline trial were greater and remained increased above baseline values for a longer period (4 hours) than during the hypertonic saline trial (2.
5 hours).
It was concluded for this model of endotoxemia, that iv administered hypertonic saline solution was associated with more-desirable cardiovascular and metabolic responses than was an equal volume of isotonic saline solution.
Related Results
Hypertonic saline in ICU setting: what is its position? A systematic review and empirical analysis
Hypertonic saline in ICU setting: what is its position? A systematic review and empirical analysis
Abstract
Background
Fluid overload has been linked to poor outcomes in the critically ill in recent years, with multiple studies showing an increase...
Sublethal Predation
Sublethal Predation
Sublethal predation is distinguished from lethal predation by survival of the prey. Predators may injure or only partially consume prey, and such injury and loss of biomass can inf...
Comparison of Hypertonic Saline with Normal Saline Nebulization in the Management of Bronchiolitis in Children
Comparison of Hypertonic Saline with Normal Saline Nebulization in the Management of Bronchiolitis in Children
Objective: “To compare the outcome of hypertonic saline with normal saline nebulization in management of bronchiolitis in children” Study design: Randomized controlled trial. Study...
LONG-TERM USE OF INHALED HYPERTONIC SALINE IN CHILDREN AND ADOLESCENTS WITH CYSTIC FIBROSIS: EXPERIENCE FROM A TERTIARY CARE CENTER IN A LOW AND MIDDLE INCOME COUNTRY
LONG-TERM USE OF INHALED HYPERTONIC SALINE IN CHILDREN AND ADOLESCENTS WITH CYSTIC FIBROSIS: EXPERIENCE FROM A TERTIARY CARE CENTER IN A LOW AND MIDDLE INCOME COUNTRY
Background Long term hypertonic saline use has been found to improve mucus transport, airway hydration, and mucociliary clearance in patients with cystic fibrosis. However, the eff...
Chest Wall Hydatid Cysts: A Systematic Review
Chest Wall Hydatid Cysts: A Systematic Review
Abstract
Introduction
Given the rarity of chest wall hydatid disease, information on this condition is primarily drawn from case reports. Hence, this study systematically reviews t...
P42 The impact of a change to hospital guidelines on prescribing practices of nebulised 3% w/v ‘hypertonic’ saline
P42 The impact of a change to hospital guidelines on prescribing practices of nebulised 3% w/v ‘hypertonic’ saline
AimsRecent conclusive evidence has suggested that, contrary to previous limited evidence, there is no benefit to the use of 3% hypertonic saline (3% HS) in the treatment of bronchi...
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Abstract
Introduction
Hospitals are high-risk environments for infections. Despite the global recognition of these pathogens, few studies compare microorganisms from community-acqu...
Comparison of nebulised 3% hypertonic saline with ipratropium bromide in treatment of children with bronchiolitis: a randomized control trial
Comparison of nebulised 3% hypertonic saline with ipratropium bromide in treatment of children with bronchiolitis: a randomized control trial
Introduction:
Several drugs are in use for nebulization in children with acute bronchiolitis and no study has yet been conducted to compare the treatment outcome of neb...

